It is a pharma private limited company based in Siwan, Bihar, India, established in 2004.
2004 | Siwan, Bihar, India | ActiveSanjeewani Drug And Diagnostics Private Limited, a active private limited company, was established on 22 September 2004 in Siwan, Bihar, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230BR2004PTC010952. Registered under ROC Roc Patna. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Its leadership includes Urmila Thakur (Director), Vishal Ranjan (Director), Kumar Deoranjan Singh (Director). It holds ₹12.20 Cr open charges and no settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.-158,Hospital Road,Siwan Dist-Siwan, Siwan, Bihar, 841226.
U24230BR2004PTC010952
010952
22 September 2004
₹0.50 M
₹0.20 M
Roc Patna
Unlisted
Active
Explore comprehensive insights into Sanjeewani Drug And Diagnostics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Urmila Thakur | Director | 22 Sep 2004 | Current |
| Vishal Ranjan | Director | 06 Feb 2015 | Current |
| Kumar Deoranjan Singh | Director | 22 Sep 2004 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sanjeewani Drug And Diagnostics Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 8.31% decrease. The company also saw a substantial improvement in profitability, with a 38.54% increase in profit. The company's net worth moved up by a moderate rise of 6.68%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Sanjeewani Drug And Diagnostics had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹122,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Jul 2025 | Indian Bank | ₹1.50 Cr | Open |
| 01 Jun 2020 | State Bank Of India | ₹5.50 M | Open |
| 16 Apr 2020 | State Bank Of India | ₹2.50 M | Open |
| 01 Mar 2018 | State Bank Of India | ₹9.90 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sanjeewani Drug And Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sanjeewani Drug And Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanjeewani Drug And Diagnostics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Indian Bank amounted to Rs. 15.00 M with Charge ID 101146472 was registered on 25 Jul 2025. was completed.
The activity Sanjeewani Drug And Diagnostics Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was completed.
The activity Sanjeewani Drug And Diagnostics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Patna. was completed.
A charge with State Bank Of India of Rs. 99.00 M registered on 01 Mar 2018 with Charge ID 100179696 was modified on 03 Feb 2024. was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 5.50 M with Charge ID 100344158 was registered on 01 Jun 2020. was documented.
Progress on A charge with State Bank Of India amounted to Rs. 2.50 M with Charge ID 100334364 was registered on 16 Apr 2020. was documented.
The CIN of Sanjeewani Drug And Diagnostics Private Limited is U24230BR2004PTC010952.
Sanjeewani Drug And Diagnostics Private Limited is headquartered at Plot No.-158,Hospital Road,Siwan Dist-Siwan, Siwan, Bihar, 841226.
Sanjeewani Drug And Diagnostics Private Limited was incorporated on 22 September 2004.
The current directors of Sanjeewani Drug And Diagnostics Private Limited are
The primary industry of Sanjeewani Drug And Diagnostics Private Limited is Trade.
Sanjeewani Drug And Diagnostics Private Limited is unlisted.
The authorized capital of Sanjeewani Drug And Diagnostics Private Limited is ₹0.50 M, and the paid-up capital is ₹0.20 M.
The compliance status of Sanjeewani Drug And Diagnostics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX